American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 898-910 , May 2009

Critical Care Nephrology: Core Curriculum 2009

  • Kathleen D. Liu, MD, PhD, MAS

      Affiliations

    • Corresponding Author InformationAddress correspondence to Kathleen D. Liu, MD, PhD, MAS, Division of Nephrology, Department of Medicine, Critical Care Medicine, Department of Anesthesia, Box 0532, University of California, San Francisco, San Francisco, CA 94133

References 

  1. Parrillo J. Approach to the patient with shock. In:  Goldman L,  Ausiello D editor. Cecil Medicine (ed 23), chap 107. Philadelphia, PA: Saunders Elsevier; 2007;
  2. Herget-Rosenthal S, Saner F, Chawla LS. Approach to hemodynamic shock and vasopressors. Clin J Am Soc Nephrol. 2008;3:546–553
  3. Davison D, Junker C. Advances in critical care for the nephrologist: Hemodynamic monitoring and volume management. Clin J Am Soc Nephrol. 2008;3:554–561
  4. Chawla LS, Zia H, Gutierrez G, Katz NM, Seneff MG, Shah M. Lack of equivalence between central and mixed venous oxygen saturation. Chest. 2004;126:1891–1896
  5. Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med. 2003;348:5–14
  6. Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med. 2006;354:2213–2224
  7. Richard C, Warszawski J, Anguel N, et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: A randomized controlled trial. JAMA. 2003;290:2713–2720
  8. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–2256
  9. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2007;17:CD000567
  10. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125–139
  11. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis (The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine). Chest. 1992;101:1644–1655
  12. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310
  13. Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med. 2000;28:2758–2765
  14. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877–887
  15. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368–1377
  16. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709
  17. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005;353:1332–1341
  18. Nadel S, Goldstein B, Williams MD, et al. Drotrecogin alfa (activated) in children with severe sepsis: A multicentre phase III randomised controlled trial. Lancet. 2007;369:836–843
  19. Barie PS. “All in” for a huge pot: The PROWESS-SHOCK trial for refractory septic shock. Surg Infect (Larchmt). 2007;8:491–494
  20. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36:1937–1949
  21. Cooper MS, Stewart PM. Adrenal insufficiency in critical illness. J Intensive Care Med. 2007;22:348–362
  22. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862–871
  23. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111–124
  24. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS (Definitions, mechanisms, relevant outcomes, and clinical trial coordination). Am J Respir Crit Care Med. 1994;149:818–824
  25. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334–1349
  26. Liu KD, Matthay MA. Advances in critical care for the nephrologist: Acute lung injury/ARDS. Clin J Am Soc Nephrol. 2008;3:578–586
  27. Brower RG, Shanholtz CB, Fessler HE, et al. Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients. Crit Care Med. 1999;27:1492–1498
  28. Liu KD, Matthay MA, Chertow GM. Evolving practices in critical care and potential implications for management of acute kidney injury. Clin J Am Soc Nephrol. 2006;1:869–873
  29. Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564–2575
  30. Brower R, Lanken P, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med. 2004;351:327–336
  31. Meade MO, Cook DJ, Guyatt GH, et al. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA. 2008;299:637–645
  32. Mercat A, Richard JC, Vielle B, et al. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: A randomized controlled trial. JAMA. 2008;299:646–655
  33. Imai Y, Parodo J, Kajikawa O, et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA. 2003;289:2104–2112
  34. Choi WI, Quinn DA, Park KM, et al. Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am J Respir Crit Care Med. 2003;167:1627–1632
  35. Kuiper JW, Groeneveld AB, Slutsky AS, Plotz FB. Mechanical ventilation and acute renal failure. Crit Care Med. 2005;33:1408–1415
  36. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416
  37. Shorr AF, Sherner JH, Jackson WL, Kollef MH. Invasive approaches to the diagnosis of ventilator-associated pneumonia: A meta-analysis. Crit Care Med. 2005;33:46–53
  38. Kollef MH. Diagnosis of ventilator-associated pneumonia. N Engl J Med. 2006;355:2691–2693
  39. The Canadian Critical Care Trials Group: A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355:2619–2630
  40. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249–1272
  41. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: Implications for preventive strategies. Medicine (Baltimore). 2002;81:466–479
  42. Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: A randomized controlled trial. JAMA. 2008;299:2413–2422
  43. Safdar N, Fine JP, Maki DG. Meta-analysis: Methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med. 2005;142:451–466
  44. Band J. Treatment of central venous catheter-related infections. 2008;Up To Date March 12
  45. Stralovich-Romani A, Mahutte C, Luce J. Nutritional and ethical principles in critical illness and injury. In:  George R,  Light R,  Matthay M,  Matthay R editor. Chest Medicine. (ed 5). Philadelphia, PA: Lippincott Williams & Wilkins; 2005;p. 497–516
  46. Liu KD, Stralovich-Romani A, Chertow GM. Nutrition support for adult patients with acute renal failure. In:  Merritt R editors. American Society for Parenteral and Enteral Nutrition (ASPEN) Nutrition Support Guidelines. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2006;p. 281–286
  47. Fiaccadori E, Maggiore U, Giacosa R, et al. Enteral nutrition in patients with acute renal failure. Kidney Int. 2004;64:999–1004
  48. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patient. N Engl J Med. 2001;345:1359–1367
  49. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449–461
  50. Schetz MRC. Classical and alternative indications for continuous renal replacement therapy. Kidney Int Suppl. 1999;66:S129–S132
  51. Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes. 2006;55:3151–3159
  52. Thomas G, Rojas MC, Epstein SK, Balk EM, Liangos O, Jaber BL. Insulin therapy and acute kidney injury in critically ill patients: A systematic review. Nephrol Dial Transplant. 2007;22:2849–2855
  53. Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, Van den Berghe G. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol. 2008;19:571–578
  54. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA. 2008;300:933–944
  55. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care (Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group). N Engl J Med. 1999;340:409–417
  56. Corwin HL, Gettinger A, Fabian TC, et al. Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med. 2007;357:965–976
  57. Phrommintikul A, Haas SJ, Elsik M, Krum H. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis. Lancet. 2007;369:381–388
  58. Bennett CL, Silver SM, Djulbegovic B, et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. JAMA. 2008;299:914–924
  59. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: A meta-analysis. Crit Care Med. 2008;36:610–617
  60. Vinsonneau C, Camus C, Combes A, et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: A multicentre randomised trial. Lancet. 2006;368:379–385
  61. Subramanian S, Venkataraman R, Kellum J. Influence of dialysis membranes on outcomes in acute renal failure: A meta-analysis. Kidney Int. 2002;62:1819–1823
  62. Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7–20
  63. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008;19:1233–1238
  64. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet. 2000;356:26–30
  65. Schiffl H, Lang S, Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med. 2002;346:305–310
  66. Liu KD, Himmelfarb J, Paganini E, et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol. 2006;1:915–919
  67. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL. Timing of renal replacement therapy initiation in acute renal failure: A meta-analysis. Am J Kidney Dis. 2008;52:272–284
  68. Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am. 2008;92:761–794viii
  69. Auzinger G, Wendon J. Intensive care management of acute liver failure. Curr Opin Crit Care. 2008;14:179–188
  70. Humphreys BD, Forman JP, Zandi-Nejad K, Bazari H, Seifter J, Magee CC. Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital. Am J Kidney Dis. 2005;46:143–146
  71. Kulig K. Aspirin intoxication. In:  Parsons P,  Wiener-Kronish J editor. Critical Care Secrets. (ed 4). Philadelphia, PA: Mosby Elsevier; 2007;p. 515–518
  72. Megarbane B, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005;31:189–195
  73. Sivilotti M, Winchester J. Methanol and ethylene glycol poisoning. 2008;Up to Date May 15
  74. Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med. 1994;97:383–389
  75. Chu J, Stolbach A. Metformin poisoning. 2008;Up To Date October:16.3
  76. Kam PC, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007;62:690–701
  77. Palmer BF. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab. 2003;14:182–187

 Originally published online as doi:10.1053/j.ajkd.2008.12.018 on March 23, 2009.

PII: S0272-6386(09)00048-1

doi: 10.1053/j.ajkd.2008.12.018

American Journal of Kidney Diseases
Volume 53, Issue 5 , Pages 898-910 , May 2009

Article Tools